Cerence IncCRNC
Price$8.10Intrinsic value$15.7795% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $309.5M-6.6% YoYTTM through 30 Jun 2026
Net Income -$15.4MTTM through 30 Jun 2026
Free Cash Flow $78.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin73.7%
EBITDA Margin11.9%
Operating Margin-3.8%
Net Margin-5.0%

Returns

-12.4%ROE
-3.2%ROA
-6.6%ROIC

Balance Sheet Health

Debt / Equity1.09x
Current Ratio1.90x
Net Debt$64.4M
Cash & Equivalents$108.3M

Quality Metrics

Altman Z-Score-0.78
Piotroski F-Score6 / 9
FCF Margin25.4%
Rule of 4027.4
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $251.8M
Diluted EPS-$0.36TTM
'19'20'21'22'23'24'25
FY2025: $-0.43

Dividend

No dividend

Capital Allocation

R&D Spend$110.6M
Capex Intensity2.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.